Skip to main content
  • EN
  • FI
  • SV
Login

Main navigation

  • About FinnGen
    • Summary & Goals
      • Goals
      • FinnGen 1-2
      • FinnGen 3 (2023-2027)
    • Consortium
      • Partners
      • Funding
      • Governance
      • Steering Committee Members
      • Scientific Committee Members
      • Teams
      • Collaboration
    • Impact
      • National Impact
      • National Research Network
      • Open Science
      • Research Highlights
    • Why Finland?
      • Biobank Network
      • Legislative Review
      • National Registries
      • Population Genetic History
      • Industry partners
    • Mediabank
  • For Researchers
    • Research Activities
      • Core Analyses
      • Disease Task Forces
      • Expansion Areas
      • Global Initiatives
    • Cohort and Data
      • Register Data
      • Basic Characteristics
      • Clinical Endpoints
      • Genetic Data
      • Laboratory Values
      • Other Phenotype Data
      • Recruitment
      • Other Biological Data
      • Data Available
    • Accessing Data, Results & Tools
      • Access results
      • Computing environment
      • How we collaborate
      • Partner researchers
      • Public data releases
      • Tools
    • Publications
    • Researcher FAQ
  • For Participants
    • Participation
      • Study Participants
      • Biobanks' Role in FinnGen
      • Biobank Contact Information
      • Recall Studies
      • Questions and answers
    • Data Protection and Security
      • Data Protection
      • Data Security
      • Sample & Data Flow
      • Data Protection Statement
    • Significance
      • Videos
  • News
  • EN
  • FI
  • SV

Links

  • PheWeb
  • Risteys
  • Meta-analysis Pheweb (FG-MVP-UKBB)
  • FinnGen handbook
  • Meta-analysis Pheweb (FG-UKBB)
  • Coding variant browser
  • Endpoint Browser
  • FinnGen GITHUB
  • LAVAA volcano plot
  • Multiple Manhattan Plot
  • Variant Cluster Corrector
  • Variant Cluster Call Corrector
Breadcrumb
  1. Home

Effect of tissue-grouped regulatory variants associated to type 2 diabetes in related secondary outcomes

Submitted by Frida Mäkelä on Thu, 03/16/2023 - 10:23
  • Read more about Effect of tissue-grouped regulatory variants associated to type 2 diabetes in related secondary outcomes

Mendelian randomization study shows a causal effect of asthma on epilepsy risk

Submitted by Frida Mäkelä on Thu, 03/16/2023 - 10:20
  • Read more about Mendelian randomization study shows a causal effect of asthma on epilepsy risk

Processed meat, red meat, white meat, and digestive tract cancers: A two-sample Mendelian randomization study

Submitted by Frida Mäkelä on Thu, 03/16/2023 - 10:18
  • Read more about Processed meat, red meat, white meat, and digestive tract cancers: A two-sample Mendelian randomization study

Causal associations between site-specific cancer and diabetes risk: A two-sample Mendelian randomization study

Submitted by Frida Mäkelä on Thu, 03/16/2023 - 10:15
  • Read more about Causal associations between site-specific cancer and diabetes risk: A two-sample Mendelian randomization study

Causal effect of psychiatric disorders on epilepsy: A two-sample Mendelian randomization study

Submitted by Frida Mäkelä on Thu, 03/16/2023 - 10:10
  • Read more about Causal effect of psychiatric disorders on epilepsy: A two-sample Mendelian randomization study

Therapeutic targets for inflammatory bowel disease: proteome-wide Mendelian randomization and colocalization analyses

Submitted by Frida Mäkelä on Thu, 03/16/2023 - 10:06
  • Read more about Therapeutic targets for inflammatory bowel disease: proteome-wide Mendelian randomization and colocalization analyses

Causal Associations of PM2.5 and GDM: A Two-Sample Mendelian Randomization Study

Submitted by Frida Mäkelä on Thu, 03/16/2023 - 10:04
  • Read more about Causal Associations of PM2.5 and GDM: A Two-Sample Mendelian Randomization Study

Systemic inflammatory regulators and proliferative diabetic retinopathy: A bidirectional Mendelian randomization study

Submitted by Frida Mäkelä on Thu, 03/16/2023 - 09:44
  • Read more about Systemic inflammatory regulators and proliferative diabetic retinopathy: A bidirectional Mendelian randomization study

Mendelian randomization and clinical trial evidence supports TYK2 inhibition as a therapeutic target for autoimmune diseases

Submitted by Frida Mäkelä on Thu, 03/16/2023 - 09:41
  • Read more about Mendelian randomization and clinical trial evidence supports TYK2 inhibition as a therapeutic target for autoimmune diseases

No Evidence of a Genetic Causal Relationship between Ankylosing Spondylitis and Gut Microbiota: A Two-Sample Mendelian Randomization Study

Submitted by Frida Mäkelä on Thu, 03/16/2023 - 09:39
  • Read more about No Evidence of a Genetic Causal Relationship between Ankylosing Spondylitis and Gut Microbiota: A Two-Sample Mendelian Randomization Study

Pagination

  • First page « First
  • Previous page ‹ Previous
  • …
  • Page 377
  • Page 378
  • Page 379
  • Page 380
  • Current page 381
  • Page 382
  • Page 383
  • Page 384
  • Page 385
  • …
  • Next page Next ›
  • Last page Last »
Subscribe to

Contact us

Contact person
finngen-info@helsinki.fi
Follow us on Bluesky
@finngen.bsky.social

Lead organisations

The University of Helsinki is the organization responsible for the FinnGen research project. The Finnish consortium partners include all Finnish public biobanks and their background organisations, so the project covers the whole of Finland. All partners are listed on this page.

About the website

Accessibility statement